Transporter-mediated drug drug interactions
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: ZHANG, Lei (Silver Spring, United States of America)
Pharmacokinetic drug interactions can lead to serious adverse events. Evaluation of a new molecular entity (NME)'s drug-drug interaction potential is an integral part of drug development and regulatory review prior to its market approval. Transporters are expressed in varying abundance in all tissues in the body where they govern the access of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.